Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Takeda Sees Mainstays Tiding It Over Upcoming Expiries
Velcade First Up
May 12 2022
•
By
Ian Haydock
Japan's biggest pharma firm expecting JPY1tn core operating profit • Source: Ian Haydock/Scrip
More from Japan
More from Focus On Asia